2-phenyl-3,6-dihydro-2H-2,6-methano-1,3,5-benzoxadiazocin-9-ol (69536-25-0)

Identification
Name:	2-phenyl-3,6-dihydro-2H-2,6-methano-1,3,5-benzoxadiazocin-9-ol
Synonyms:	NSC302588;NSC-302588;69536-25-0
CAS:	69536-25-0
Molecular Formula:	C₁₆H₁₄N₂O₂
Molecular Weight:	266.2946
InChI:	InChI=1/C16H14N2O2/c19-12-6-7-13-14-9-16(18-10-17-14,20-15(13)8-12)11-4-2-1-3-5-11/h1-8,10,14,19H,9H2,(H,17,18)
Molecular Structure:
Properties
Flash Point:	288°C
Boiling Point:	552.6°C at 760 mmHg
Density:	1.36g/cm³
Refractive index:	1.696
Flash Point:	288°C
Safety Data

Other Product

4-amino-5,6-dihydro-2H-2,6-methano-1,3,5-benzoxadiazocin-9-ol
1H-4,1,5-Benzoxadiazocin-2(3H)-one, 8-chloro-3-methyl-6-phenyl-
9-methoxy-5,6-dihydro-2H-2,6-methano-1,3,5-benzoxadiazocin-4-amine
Butanoic acid,2-methyl-,6-(acetyloxy)octahydro-2,2,5a,9-tetramethyl-5-[(1-oxo-3-phenyl-2-propenyl)oxy]-2H-3,9a-methano-1-benzoxepin-7-ylester (9CI)
2H-1-Benzopyran-6-ol,3,4-dihydro-2,2,7,8-tetramethyl-5-[[(3-phenyl-2-propenyl)oxy]methyl]-
2-Propenoic acid,3-phenyl-,(3R,5S,5aS,6R,7S,9R,9aS)-7-(acetyloxy)octahydro-6-hydroxy-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-5-ylester, (2E)-
2-Propenoic acid,3-phenyl-,(3R,5S,5aR,6R,7S,9R,9aS)-6-(acetyloxy)-7-(benzoyloxy)octahydro-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-5-ylester, (2E)-
2-Propenoic acid,3-phenyl-,(3R,5S,5aR,6R,7S,9R,9aS)-6-(acetyloxy)octahydro-7-hydroxy-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-5-ylester, (2E)-
2-Propenoic acid,3-phenyl-,(3R,5S,5aS,6S,9R,9aS,10R)-6-(acetyloxy)-5-(benzoyloxy)octahydro-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-10-ylester, (2E)-
Spiro[furan-3(2H),6'(7'H)-[1H-3,9a]methano[2]benzoxepin]-1',2-dione,5-(3-furanyl)octahydro-7'-methylene-, (3S,3'R,5S,5'aS,9'aR)-
2H-1-Benzopyran-6-ol,3,4-dihydro-2,7,8-trimethyl-5-[[(3-phenyl-2-propenyl)oxy]methyl]-2-(4,8,12-trimethyltridecyl)-
2-Propenoic acid,3-phenyl-,(3R,5S,5aS,6S,9S,9aS,10R)-10-(acetyloxy)octahydro-9-hydroxy-6-[(hydroxyacetyl)oxy]-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-5-ylester, (2E)- (9CI)
2-Propenoic acid,3-phenyl-,(3R,5S,5aR,6R,7S,9S,9aS,10R)-7,10-bis(acetyloxy)-5-(benzoyloxy)octahydro-9-hydroxy-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-6-ylester, (2E)- (9CI)
2,6-Methano-2H-1-benzoxocin-7-ol,3,6-dihydro-2-methyl-5-(1-methylethyl)-9-pentyl- (9CI)
3-Pyridinecarboxylicacid,(3R,4R,5S,5aS,6S,9S,9aS,10R)-10-(acetyloxy)-5a-[(acetyloxy)methyl]-5-(benzoyloxy)octahydro-9-hydroxy-2,2,9-trimethyl-6-[[(2E)-1-oxo-3-phenyl-2-propen-1-yl]oxy]-2H-3,9a-methano-1-benzoxepin-4-ylester
3-Pyridinecarboxylicacid,(3R,5S,5aR,6R,7R,9S,9aS,10R)-5-(acetyloxy)octahydro-7,9-dihydroxy-2,2,5a,9-tetramethyl-6-[[(2E)-1-oxo-3-phenyl-2-propen-1-yl]oxy]-2H-3,9a-methano-1-benzoxepin-10-ylester
3-Pyridinecarboxylicacid,(3R,4R,5S,5aS,6S,9S,9aS,10R)-10-(acetyloxy)-5a-[(acetyloxy)methyl]-5-(benzoyloxy)octahydro-9-hydroxy-2,2,9-trimethyl-6-[[(2Z)-1-oxo-3-phenyl-2-propen-1-yl]oxy]-2H-3,9a-methano-1-benzoxepin-4-ylester
4-(6-chloro-2-methylsulfanyl-purin-9-yl)-2-(hydroxymethyl)-3,4-dihydro-2H-pyran-3-ol
2,6-Methano-3-benzazocin-8-ol,1,2,3,4,5,6-hexahydro-11-methyl-6-phenyl-3-(2-propen-1-yl)-, (2S,6S,11R)-
2-Propenoic acid,3-phenyl-,(3R,5S,5aR,6R,7S,9R,9aS)-6-(acetyloxy)octahydro-2,2,5a,9-tetramethyl-7-(2-methyl-1-oxopropoxy)-2H-3,9a-methano-1-benzoxepin-5-ylester, (2E)- (9CI)